Why Hard Science and Medicine Is Getting Mushy
Arthur Caplan, one of America’s top medical ethicists, is worried about pollution. Not the kind that ruins our oceans or makes it hard for us to breathe, but the kind that poses a threat to the “trustworthiness, utility, and value of science and medicine.”
Caplan, who directs the Division of Medical Ethics at NYU Langone Medical Center, wrote a blistering essay in last week’s Mayo Clinic Proceedings, saying, "The pollution of science and medicine by plagiarism, fraud, and predatory publishing is corroding the reliability of research. Yet neither the leadership nor those who rely on the truth of science and medicine are sounding the alarm loudly or moving to fix the problem with appropriate energy."
He goes on to cite three causes of publication pollution, which can undermine these areas of “hard science” that should be sacrosanct.
- The proliferation of journals that recruit authors who pay to get their articles published. Despite having substandard or no peer view, these "predatory publishers" now comprise an estimated 25 percent of all open-access journals. "Not only do they provide opportunities for the unscrupulous in academia and industry to pad their curriculum vitaes and bibliographies with bogus articles and editorial appointments, they also make it difficult for those involved in the assessment and promotion of scholars to discern value from junk," writes Dr. Caplan.
- Research misconduct, like falsifying or fabricating data or concealing serious violations. Fourteen percent of scientists report that their colleagues falsify data, and 72 percent report other questionable practices, according to one 2009 study published in PLoS One.
- Plagiarism, which, according to a 2010 Nature article was "staggering," requiring editors to spend "inordinate amounts of time" checking submissions they receive.
Top Reads from The Fiscal Times:
- The Biggest Outrage in Atlanta’s Crazy Teacher Cheating Case
- $45 Billion in Tax Dollars Goes Missing in Afghanistan
- How Dark Money Is Distorting Politics and Undermining Democracy
Chart of the Day: SALT in the GOP’s Wounds
The stark and growing divide between urban/suburban and rural districts was one big story in this year’s election results, with Democrats gaining seats in the House as a result of their success in suburban areas. The GOP tax law may have helped drive that trend, Yahoo Finance’s Brian Cheung notes.
The new tax law capped the amount of state and local tax deductions Americans can claim in their federal filings at $10,000. Congressional seats for nine of the top 25 districts where residents claim those SALT deductions were held by Republicans heading into Election Day. Six of the nine flipped to the Democrats in last week’s midterms.
Chart of the Day: Big Pharma's Big Profits
Ten companies, including nine pharmaceutical giants, accounted for half of the health care industry's $50 billion in worldwide profits in the third quarter of 2018, according to an analysis by Axios’s Bob Herman. Drug companies generated 23 percent of the industry’s $636 billion in revenue — and 63 percent of the total profits. “Americans spend a lot more money on hospital and physician care than prescription drugs, but pharmaceutical companies pocket a lot more than other parts of the industry,” Herman writes.
Chart of the Day: Infrastructure Spending Over 60 Years
Federal, state and local governments spent about $441 billion on infrastructure in 2017, with the money going toward highways, mass transit and rail, aviation, water transportation, water resources and water utilities. Measured as a percentage of GDP, total spending is a bit lower than it was 50 years ago. For more details, see this new report from the Congressional Budget Office.
Number of the Day: $3.3 Billion
The GOP tax cuts have provided a significant earnings boost for the big U.S. banks so far this year. Changes in the tax code “saved the nation’s six biggest banks $3.3 billion in the third quarter alone,” according to a Bloomberg report Thursday. The data is drawn from earnings reports from Bank of America, Citigroup, Goldman Sachs, JPMorgan Chase, Morgan Stanley and Wells Fargo.
Clarifying the Drop in Obamacare Premiums
We told you Thursday about the Trump administration’s announcement that average premiums for benchmark Obamacare plans will fall 1.5 percent next year, but analyst Charles Gaba says the story is a bit more complicated. According to Gaba’s calculations, average premiums for all individual health plans will rise next year by 3.1 percent.
The difference between the two figures is produced by two very different datasets. The Trump administration included only the second-lowest-cost Silver plans in 39 states in its analysis, while Gaba examined all individual plans sold in all 50 states.